Home
>
National Drug Code (NDC)
>
mercaptopurine
mercaptopurine - 49884-922-04 - (mercaptopurine)
Drug Information of mercaptopurine
| Product NDC: | 49884-922 |
| Proprietary Name: | mercaptopurine |
| Non Proprietary Name: | mercaptopurine |
| Active Ingredient(s): | 50 mg/1 & nbsp; mercaptopurine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of mercaptopurine
| Product NDC: | 49884-922 |
| Labeler Name: | Par Pharmaceutical Companies, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040461 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040211 |
Package Information of mercaptopurine
| Package NDC: | 49884-922-04 |
| Package Description: | 250 TABLET in 1 BOTTLE (49884-922-04) |
NDC Information of mercaptopurine
| NDC Code | 49884-922-04 |
| Proprietary Name | mercaptopurine |
| Package Description | 250 TABLET in 1 BOTTLE (49884-922-04) |
| Product NDC | 49884-922 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mercaptopurine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20040211 |
| Marketing Category Name | ANDA |
| Labeler Name | Par Pharmaceutical Companies, Inc. |
| Substance Name | MERCAPTOPURINE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
